🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

325 results for “Disc” Clear

  1. Celestone Cronodose suspensión inyectable, Plasma rich in growth factors

    Ology Bioservices Ireland LTD

    Low back pain

    approved small molecule active

    1 trial
  2. Cisplatin Accord Healthcare 1 mg/ml concentraat voor oplossing voor infusie

    Disc Medicine

    Locally advanced head and neck squamous cell carcinoma

    approved small molecule active

    1 trial
  3. Conoxia® Vloeibaar, 100% v/v, medicinaal gas, cryogeen

    Disc Medicine

    Pulmonary Hypertension, Coronary Microvascular Dysfunction, Hypoxia, Heart Failure

    approved small molecule active

    1 trial
  4. Cymbalta 30 mg hard gastro-resistant capsules, Vimpat 50 mg film-coated tablets

    Disc Medicine

    chemotherapy-induced neuropathic pain

    approved small molecule active

    1 trial
  5. DIGOXIN

    Disc Medicine

    heart failure

    approved small molecule active

    1 trial
  6. DOTAREM 0,5 mmol/ml oplossing voor injectie in injectieflacons.

    Disc Medicine

    Breast Cancer

    approved small molecule active

    1 trial
  7. Dexamethasone 4 mg tablets, Dexamethasone Phosphate 4 mg/ml Solution for Injection

    Disc Medicine

    Solid tumors

    approved small molecule active

    1 trial
  8. Dysport 300 E, poeder voor oplossing voor injectie

    Disc Medicine

    Dystonic tremor syndrome

    approved small molecule active

    1 trial
  9. Fentanyl hameln 50 microgram/ml, oplossing voor injectie, Narcan Nasal Spray, Sufentanil Eurocept 5 microgram/ml, oplossing voor injectie, Zofran 4 Injectie, Naloxon HCl-hameln 0,4 mg/ml, oplossing voor injectie/infusie

    Disc Medicine

    healthy volunteers, opioid use disorder

    approved small molecule active

    1 trial
  10. Ferinject

    Disc Medicine

    Patients with Aortic stenosis and Iron deficiency

    approved small molecule active

    1 trial
  11. Fluconazol Accord 50 mg capsules, hard, Diflucan I.V. 2 mg/ml, oplossing voor infusie, Diflucan 100 mg, capsule, hard, Diflucan 10 mg/ml, poeder voor orale suspensie

    Disc Medicine

    Fungal infection

    approved small molecule active

    1 trial
  12. Fluenz nasal spray suspension Influenza vaccine (live attenuated, nasal)

    Disc Medicine

    Influenza

    approved small molecule active

    1 trial
  13. Foliumzuur Aurobindo 5 mg, tabletten, XELJANZ 5 mg film-coated tablets, METHOTREXAAT SANDOZ 2,5 MG, TABLETTEN, Methotrexaat Teva 20,0 mg, Oplossing voor injectie in een voorgevulde pen, Enbrel 50 mg solution for injection in pre-filled syringe, Methotrexaat Teva 25,0 mg, Oplossing voor injectie in een voorgevulde pen, Methotrexaat Teva 15 mg, Oplossing voor injectie in een voorgevulde pen

    Disc Medicine

    Psoriatic arthritis

    approved small molecule active

    1 trial
  14. HALOPERIDOL, CLOZAPINE, TIAPRIDE, SERTINDOLE, PALIPERIDONE, OLANZAPINE, SULPIRIDE, ARIPIPRAZOLE, LURASIDONE, RISPERIDONE, AMISULPRIDE, CHLORPROMAZINE, PIMOZIDE, QUETIAPINE

    Disc Medicine

    HAMLETT compares regular treatment guidelines for patients in remission after a first episode of psychosis, namely continuation with antipsychotic medication for at least one year, with early dose reduction/discontinuation.

    approved small molecule active

    1 trial
  15. Hemlibra 150 mg/mL solution for injection, Hemlibra 30 mg/mL solution for injection, Hemlibra 30 mg/mL solution for injection, Hemlibra 150 mg/mL solution for injection, Hemlibra 150 mg/mL solution for injection, Hemlibra 150 mg/mL solution for injection

    Disc Medicine

    Congenital Haemophilia A

    approved small molecule active

    1 trial
  16. IMATINIB , PONATINIB , BOSUTINIB, NILOTINIB, DASATINIB

    Disc Medicine

    Chronic myeloid leukaemia

    approved small molecule active

    1 trial
  17. INDOCYANINE GREEN

    Disc Medicine

    cervical cancer stage I-IIA

    approved small molecule active

    1 trial
  18. IRON OXIDE (E172)

    Disc Medicine

    Glioblastoma

    approved small molecule active

    1 trial
  19. Kenacort-A 10, suspensie voor injectie 10 mg/ml, Kenacort-T 40 mg/ml injektionsvätska, suspension

    Disc Medicine

    Strictures after esophageal atresia repair

    approved small molecule active

    1 trial
  20. Kenacort-A 40, suspensie voor injectie 40 mg/ml, Jyseleca 200 mg film-coated tablets

    Disc Medicine

    Rheumatoid arthritis

    approved small molecule active

    1 trial
  21. Kerendia 20 mg film-coated tablets, Kerendia 10 mg film coated tablets, Jardiance 10 mg film-coated tablets

    Disc Medicine

    Albuminuria, Type 2 diabetes

    approved small molecule active

    1 trial
  22. Ketanest® S 25 mg/ml - Ampullen, Ketanest® S 5 mg/ml - Ampullen

    Disc Medicine

    Complex regional pain syndrome

    approved small molecule active

    1 trial
  23. Kineret 100 mg/0.67 ml solution for injection in pre-filled syringe.

    Disc Medicine

    autoimmune disorders, joint disorders synonym: Still's disease, systemic JIA

    approved small molecule active

    1 trial
  24. LACTOSE MONOHYDRATE, Clopidogrel Viatris 75 mg film coated tablets, Acetylsalicylzuur Aurobindo cardio 80 mg, tabletten., Clopidogrel Zentiva 75 mg film-coated tablets

    Disc Medicine

    (Chronic) Peripheral (occlusive) arterial disease (PAD)

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources